A randomised, double-blind, placebo-controlled study of Glypromate [glycine proline glutamate] in patients undergoing coronary artery bypass graft surgery

Trial Profile

A randomised, double-blind, placebo-controlled study of Glypromate [glycine proline glutamate] in patients undergoing coronary artery bypass graft surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2007

At a glance

  • Drugs Glycine-proline-glutamate (Primary)
  • Indications Mild cognitive impairment
  • Focus Pharmacokinetics
  • Acronyms SNUG
  • Sponsors Neuren Pharmaceuticals
  • Most Recent Events

    • 11 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top